We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$259M
AUM Growth
+$626K
Cap. Flow
-$11M
Cap. Flow %
-4.26%
Top 10 Hldgs %
27.16%
Holding
343
New
40
Increased
92
Reduced
61
Closed
71

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.71M
2
KMB icon
Kimberly-Clark
KMB
+$5.62M
3
RSG icon
Republic Services
RSG
+$5.6M
4
PG icon
Procter & Gamble
PG
+$4.06M
5
DRI icon
Darden Restaurants
DRI
+$3.95M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$4.87M
2
HPQ icon
HP
HPQ
+$4.75M
3
HUM icon
Humana
HUM
+$4.26M
4
MKL icon
Markel Group
MKL
+$4.11M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.1M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Consumer Staples 11.11%
3 Industrials 10.54%
4 Financials 9.14%
5 Healthcare 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
201
Brookfield
BN
$108B
$67K 0.03%
3,955
CME icon
202
CME Group
CME
$94.8B
$67K 0.03%
344
+64
+23% +$11.8K
CSX icon
203
CSX Corp
CSX
$93.1B
$67K 0.03%
2,604
+450
+21% +$11.6K
CB icon
204
Chubb
CB
$135B
$66K 0.03%
+447
New +$64.5K
CHTR icon
205
Charter Communications
CHTR
$18.2B
$66K 0.03%
+167
New +$62.6K
ECL icon
206
Ecolab
ECL
$79.9B
$66K 0.03%
336
+48
+17% +$8.93K
CP icon
207
Canadian Pacific Kansas City
CP
$80.5B
$65K 0.03%
1,375
-15
-1% -$670
DEO icon
208
Diageo
DEO
$53.6B
$65K 0.03%
377
-3
-0.8% -$504
LOW icon
209
Lowe's Companies
LOW
$125B
$65K 0.03%
641
+87
+16% +$9.18K
INFO
210
DELISTED
IHS Markit Ltd. Common Shares
INFO
$65K 0.03%
1,013
LAD icon
211
Lithia Motors
LAD
$8.26B
$64K 0.02%
540
SHW icon
212
Sherwin-Williams
SHW
$89.8B
$64K 0.02%
417
+81
+24% +$12.1K
AMT icon
213
American Tower
AMT
$80.4B
$62K 0.02%
+302
New +$60.7K
CELG
214
DELISTED
Celgene Corp
CELG
$62K 0.02%
+670
New +$63.6K
LLY icon
215
Eli Lilly
LLY
$1.06T
$61K 0.02%
+548
New +$64.5K
GLD icon
216
SPDR Gold Trust
GLD
$141B
$60K 0.02%
450
VZ icon
217
Verizon
VZ
$196B
$60K 0.02%
1,053
+485
+85% +$27.9K
INFY icon
218
Infosys
INFY
$50.7B
$59K 0.02%
5,522
CNI icon
219
Canadian National Railway
CNI
$76.6B
$57K 0.02%
613
INTC icon
220
Intel
INTC
$513B
$55K 0.02%
1,146
+803
+234% +$39.8K
ERIC icon
221
Ericsson
ERIC
$33.3B
$54K 0.02%
5,689
AZN icon
222
AstraZeneca
AZN
$250B
$53K 0.02%
637
ESLT icon
223
Elbit Systems
ESLT
$40.3B
$53K 0.02%
+352
New +$50.4K
GSK icon
224
GSK
GSK
$106B
$51K 0.02%
1,029
NVS icon
225
Novartis
NVS
$297B
$50K 0.02%
+552
New +$46.7K

Similar funds

Contravisory Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Contravisory Investment Management held 343 positions worth $259M, up 0.24% from $258M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management withdrew a net $11M in Q2 2019, closing 71 positions and reducing 61 holdings. Its most notable exit was Elevance Health, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Contravisory Investment Management opened a new position in AvalonBay Communities worth $3.9M.

  • Contravisory Investment Management's largest Q2 2019 buy was AvalonBay Communities: 19,217 shares worth $3.9M.
  • Contravisory Investment Management added most to Microsoft in Q2 2019, an estimated $5.71M increase.
  • Contravisory Investment Management's biggest Q2 2019 reduction was Universal Health Services, cutting an estimated $588K.
  • Contravisory Investment Management fully exited Elevance Health in Q2 2019, selling an estimated $4.87M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $259M portfolio in Q2 2019.
  • Contravisory Investment Management opened 40 new positions and closed 71 in Q2 2019.
  • Contravisory Investment Management's portfolio value rose 0.24% quarter-over-quarter to $259M.

Based on Contravisory Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.